Jason Napodano, CFA
Research analyst, medium-term horizon, biotech, small-cap

OxySure Systems' Emergency Oxygen Device Ready For Takeoff

OxySure Systems, Inc. (OTCPK:OXYS) is a medical device company with a potential breakthrough product for the delivery of medical grade oxygen for the treatment of cardiac and respiratory distress situations. The company has developed a unique platform technology, whereby medically pure oxygen is created instantly from two inert dry powders, allowing oxygen to be delivered on demand to patients when needed.

The Product

The Model 615 unit has been cleared by the U.S. Food and Drug Administration (FDA) for over-the-counter (OTC) sale without the need for a prescription (510k/Class-II). The product is also approved in South Africa, Turkey, Brazil, and Israel.

OxySure Model 615

With the Model 615 unit, oxygen is generated on demand from two inert dry...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details